Medical cannabis company WeedMD Inc. WMDWDDMF(FSE:4WE) confirmed Tuesday it has been added to the Horizons Marijuana Life Sciences Index ETF HMMJ HMLSF.
The Canadian exchange-traded fund opted for the move after completing its quarterly rebalancing last week. WeedMD had been added to the North American Marijuana Index, which is the benchmark for the HMMJ, in December.
The Index offers direct exposure to North American-listed stocks operating within the legal cannabis industry.
About WeedMD
WeedMD recently secured $17.25 million in financing through a bought deal short-form prospectus offering of approximately 36 million of its units at 48 cents per unit.
The funds are to be utilized to boost the company's growth through sales and marketing initiatives, and the advancement of its operational capacities, as well as other product development initiatives.
To further improve its performance, the company opted to strengthen its leadership team.
On the heels of appointing its Chief Legal Officer Jason Alexander to the board of directors In January, WeedMD named Executive Chairman George Scorsis as interim CEO after Angelo Tsebelis’ departure.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.